Kılınç, Oğuz

Profile Picture
Profile URL
https://hdl.handle.net/20.500.14365/7638
Name Variants
Kılınç, Oguz
Kılınc, Oğuz
Kılınç, Oğuz
Kilinc, O.
Kilinç, O.
Kilinc, Oguz
Kilinç, Oguz
Kilinç, Oğuz
Kılınç, O.
Kılınc, Oguz
Job Title
Email Address
oguz.kilinc@ieu.edu.tr
Main Affiliation
09.03. Medicine
Status
Current Staff
Website
ORCID ID
0000-0001-8923-4476
Scopus Author ID
57200243180
Turkish CoHE Profile ID
92232DC427D4BE6A
Google Scholar ID
1zjvZEkAAAAJ
WoS Researcher ID
ACF-2787-2022

Sustainable Development Goals

SDG data is not available
Documents

90

Citations

972

h-index

16

Go to Scopus profile
Documents

99

Citations

600

Go to WoS profile
Scholarly Output

6

Articles

4

Views / Downloads

6/9

Supervised MSc Theses

0

Supervised PhD Theses

0

WoS Citation Count

7

Scopus Citation Count

7

WoS h-index

1

Scopus h-index

1

Patents

0

Projects

0

WoS Citations per Publication

1.17

Scopus Citations per Publication

1.17

Open Access Source

6

Supervised Theses

0

JournalCount
Thoracic Research and Practice4
Balkan Medical Journal1
Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi1
Current Page: 1 / 1

Scopus Quartile Distribution

Competency Cloud

GCRIS Competency Cloud

Filters

2024 - 20266
Reset filters

Settings

Scholarly Output Search Results

Now showing 1 - 6 of 6
  • Thumbnail Image
    Article
    Echoes of the Past: Are E-Cigarettes the New "Light" Cigarettes
    (2026) Yıldız, E.; Kilinç, O.; Çuhadaroǧlu, Ç.
  • Thumbnail Image
    Article
    Citation - WoS: 7
    Citation - Scopus: 7
    Effectiveness of a Program To Raise Awareness About Pneumococcal Vaccination Among Physicians and Patients With Chronic Respiratory Diseases: a Multicenter Cohort Study
    (AVES, 2024) Karakurt, Z.; Yalnız, E.; Altın, S.; Oruç, Ö.; Uslu, Ö.; Veske, N.Ş.; Kılınç, O.; Sayıner, Abdullah
    OBJECTIVE: There is a need to increase patient and clinician awareness on the effectiveness of pneumococcal vaccination in at-risk groups. The aim of the study was to evaluate the effect of reminders for physicians and patients using the vaccination tracking system created in the hospital information management system (HIMS) on the vaccination rate, and the effect of pneumococcal vaccination on pneumonia-related hospitalization and mortality over a 12-month period. MATERIAL AND METHODS: This prospective observational cohort study was undertaken during a 2-year period in 3 tertiary care cen-ters. Patients were followed up for 12 months following vaccination, and hospital admissions and mortality were recorded via HIMS. During the campaign, HIMS transmitted pneumococcal immunization reminder messages in accordance with guideline recommendations to physicians’ computers and patients’ mobile phones. Educational posters on pneumococcal vaccination were posted in outpatient clinics. Regular seminars on the evidence for pneumococcal vaccination were organized. All patients who were hospitalized during the follow-up period for chronic obstructive pulmonary disease (COPD), asthma, lung cancer, or pneumonia were analyzed in relation to their vaccination history regarding clinical outcomes. RESULTS: A total of 29 530 patients were included in the study. During the study period, the annual vaccination rate increased by 74.4% and reached 4.8% in 3 hospitals (P = .001). The rates were 3.9% in patients older than 65 years without comorbidities and 5.2% in those with COPD and asthma (P = .002). In pneumococcal vaccine recipients, pneumonia-related hospital mortality was lower (relative risk (RR) = 0.19, CI 0.09-0.35, P < .001). CONCLUSION: It is possible to raise the rate of pneumococcal vaccination through awareness campaigns. Individuals with COPD and asthma are more willing to receive pneumococcal vaccination. Among patients hospitalized for pneumonia, prior pneumococcal vaccination is associated with lower mortality. © Author(s).
  • Thumbnail Image
    Article
    Turkish Thoracic Society Declaration on Peace and Health the Importance of Breathing in a World Without Ware
    (Galenos Publ House, 2026) Cetinkaya, Pelin Duru; Toreyin, Zehra Nur; Ozdemir, Hande Yuce; Yasin, Yesim; Kilinc, Oguz; Yorgancioglu, Arzu; Begic, Erencan
    War legitimizes the right to kill for its participants, equating victory with moral justification, however, this perceived legitimacy is largely Constructed on the deaths of civilians and other living beings. Medicine, by its very nature, is grounded in the principles of preserving ife, doing no harm, and adhering to scientific and ethical standards, and is therefore fundamentally opposed to the philosophy of war. Wars lead, directly and indirectly, to desaths, disability, displacement, poverty, and long-term public health disasters. Attacks on health Facilities, restrictions on access to food and water, environmental destruction, and air pollution disproportionately affect vulnerable Dopulations, particularly women and children. The psychological consequences of war often evolve into persistent neuropsychiatric conditions, including post-traumatic stress disorder, depression, and moral injury. Peace is not merely the absence of war, it is a prerequisite for health, environmental sustainability, and social well-being. The concept of positive peace strengthens health indicators hrough well-functioning institutions, equitable resource distribution, and the protection of human rights. Within this framework, health professionals and civil society organizations are critical actors in advocating for peace and in making human rights violations visible The Turkish Thoracic Society regards peace as an indispensable condition for public and respiratory health, affirms its opposition to all wars particularly the ongoing atrocities in Gaza-and reaffirms its commitment to sustained, health-based advocacy for peace,
  • Thumbnail Image
    Letter
    The Necessity of Bronchiectasis Registries - The Turkish Registry of Bronchiectasis
    (Galenos Publ House, 2026) Kizilirmak, Deniz; Martinez-Garcia, Miguel Angel; Cicek, Sedat; Coskun, Aysin Sakar; Kilinc, Oguz; Edis, Ebru Cakir
  • Thumbnail Image
    Letter
    Can E-Cigarettes Be the Source of Lead Toxicity
    (AVES, 2025) Yılmaz, Seda; Kılınc, Oguz; Atik, Merve Demirci
  • Thumbnail Image
    Article
    Retrospective Evaluation of Covid-19 Incidence During Smoking Cessation Treatment With Varenicline
    (2024) Barış, Elif; Ömeroğlu Şimşek, Gökçen; Arıcı, Mualla Aylin; Gümüştekin, Mukaddes; Tosun, Metiner; Kılınç, Oğuz
    Background: Cholinergic anti-inflammatory pathway endogenously controls inflammatory processes through activation of the α7-nicotinic acetylcholine receptor (α7nAChR). Varenicline, used in smoking cessation therapy, is a full α7nAChR agonist with anti-inflammatory effects. In this study, the frequency of coronavirus disease (COVID-19) was evaluated in patients using varenicline as a smoking cessation treatment. Methods: In this retrospective cross-sectional study, records of the 111 patients admitted to Smoking Cessation Outpatient Clinic of XXXXX University Faculty of Medicine during the COVID-19 pandemic were evaluated. The development of COVID-19 disease according to the status of the patients being positive for SARS-COV-2 was evaluated comparatively in patients who received varenicline or not. Additionally, the disease symptoms were questioned. Results: SARS-CoV-2 PCR positivity was not detected in any of 38 patients who regularly used varenicline out of 68 patients evaluated. SARS-CoV-2 PCR positivity was detected in 13 (43.3%) of 30 patients who received other treatments or irregularly used varenicline (p<0.001). Conclusions: Patients under smoking cessation treatment did not develop COVID-19 during the period of varenicline use compared to non-users suggesting that the medication may have a protective role in the development of COVID-19 which might be further investigated by clinical trials.